☰

Search Index Entries

Next Page
Previous Page
2178 Results
TitlePublication
Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical TrialBrieflands
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort StudyCureus
Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational StudyEuropean Journal of Medical and Health Sciences
Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases EvaluationMicrobiology & Infectious Diseases
Ivermectin Could Have Saved Millions of Lives, Why Was It SuppressedGlobal Research
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2In Vivo
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomesJournal of Infection
Ivermectin for COVID-19: Real-time meta-analysis of 99 studies
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical GuidelinesAmerican Journal of Therapeutics
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trialJournal of International Medical Research
Ivermectin prophylaxis used for COVID-19 reduces COVID-19 infection and mortality rates: A 220,517-subject, populational-level retrospective citywide observational study
Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score MatchingCureus
Ivermectin reduces in vivo coronavirus infection in a mouse experimental modelScientific Reports
Ivermectin, ‘Wonder drug’ from Japan: the human use perspectiveProceedings of the Japan Academy, Series B
Ivermectin: A Drug Worthy of a Nobel Prize, but Inaccessible for Those Who Need It
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19New Microbes and New Infections
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimenJournal of Antibiotics
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19Journal of Controlled Release
Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectationsJournal of Antibiotics
Jab Injuries Australia
Japan's H1 excess mortality highest since Covid pandemicThe Economic Times (India)
Japanese Professor Upends Ministry of Health: Disband Vax Committee, Investigate All InjuriesThe Vigilant Fox
Jeffrey Sachs on COVID-19 – “I’m pretty convinced it came out of US lab biotechnology"
Johnson & Johnson clinical trial: A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult ParticipantsNational Library of Medicine
Kansas AG sues Pfizer for misleading Kansans on COVID vaccine
Kids and Speech DelaysWPBF (West Palm Beach, FL)
Killer Jab? 24% Say Someone They Know Died From COVID-19 Vaccine
Kolaviron (Kolaflavanone), apigenin, fisetin as potential Coronavirus inhibitors: In silico investigation
Kounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and managementHuman Vaccines & Immunotherapeutics
Lab Leak - The True Origins of COVID-19
Laboratory testing for coronavirus disease (COVID-19) in suspected human cases
Lack of correlation between school mask mandates and paediatric COVID-19 cases in a large cohortJournal of Infection
Large-scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 InfectionVaccines
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context
Lasting immunity found after recovery from COVID-19
Latest statistics on England mortality data suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of Covid-19 vaccination
Legal Letter on Behalf of Physicians Regarding Covid-19 Vaccine Injuries (to heads of the DHHS, CDC, and FDA)
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)International Journal of Infectious Diseases
Lessons Learned from FEMA’s Initial Response to COVID-19
Letter from a Los Angeles Psychiatrist to his PatientsFrontline News
Letter from Ron Johnson to HHS, FDA and CDC directing them to preserve all records relating to COVID-19 vaccines
Letter from Senator Ron Johnson to Lloyd J. Austin III, Secretary of the Department of Defense
Letter from US Senators to USAID regarding funding and activities of EcoHealth Alliance
Letter of inquiry from the US House Committee on Oversight and Reform to Dr. Kristian Andersen
Letter to the Chief Executive of the UK Medicines and Healthcare Products Regulatory Agency: Urgent preliminary report of Yellow Card data up to 26th May 2021
Letter to the Editor: As an Oncologist I Am Seeing People With Stable Cancer Rapidly Progress After Being Forced to Have a BoosterDaily Sceptic
Letter to the Editor: Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional EtiologiesScience, Public Health Policy & the Law
Letter to the Editor: Meta-analysis on facemask use in community settings to prevent respiratory infection transmission shows no effectInternational Journal of Infectious Diseases
Letter to the Editor: Open Schools, Covid-19, and Child and Teacher Morbidity in SwedenNew England Journal of Medicine (NEJM)
Letter to the Editor: Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccinationJournal of Infection